Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Fique atualizado em 5 minutos sobre Psiquiatria e Neurologia Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
User created User created Anonym
OWA Status Updating trust level from 1 to 2 Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind United Kingdom newsletter Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
OWA Status Check:23461:mick.barlow@leicspart.nhs.uk:56830BDF-66FB-19F6-AF02-33B36AC883C7:Updating trust level from [2] to [4] Anonym
OWA Status Check:23455:mohan.gondhalekar@nhs.net:B29398E4-169A-1427-57B4-676EA3BB470A:Updating trust level from [2] to [0] Anonym
OWA Status Check:23433:tusharkumar.patel@nhs.net:F8757CFE-31EB-6B72-7C28-A9E7A9335F3F:Updating trust level from [2] to [0] Anonym
Newsletter opened Opened Dr. Mattingly discute abordagens durante a pandemia Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
OWA Status Updating trust level from 1 to 2 Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
OWA Status Updating trust level from 1 to 2 Anonym
User created User created Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Apoio à saúde mental em tempos de crise Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Log Type Authored on Log Message Log Node Authored by
Newsletter opened Opened Fique atualizado em 5 minutos sobre Psiquiatria e Neurologia Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
User created User created Anonym
OWA Status Updating trust level from 1 to 2 Anonym
Newsletter subscribed Newsletter subscribed - Progress in Mind United Kingdom newsletter Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
OWA Status Check:23461:mick.barlow@leicspart.nhs.uk:56830BDF-66FB-19F6-AF02-33B36AC883C7:Updating trust level from [2] to [4] Anonym
OWA Status Check:23455:mohan.gondhalekar@nhs.net:B29398E4-169A-1427-57B4-676EA3BB470A:Updating trust level from [2] to [0] Anonym
OWA Status Check:23433:tusharkumar.patel@nhs.net:F8757CFE-31EB-6B72-7C28-A9E7A9335F3F:Updating trust level from [2] to [0] Anonym
Newsletter opened Opened Dr. Mattingly discute abordagens durante a pandemia Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
OWA Status Updating trust level from 1 to 2 Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
OWA Status Updating trust level from 1 to 2 Anonym
User created User created Anonym
User created User created Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Apoio à saúde mental em tempos de crise Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym
Newsletter opened Opened Novos medicamentos têm como alvo a CGRP e seus receptores Anonym